Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HIV Seronegativity”

383 trials

Showing 20 of 383 results

Large-scale testing (Phase 3)Study completedNCT00424814
What this trial is testing

Prevention of HIV1 Mother to Child Transmission Without Nucleoside Analogue Reverse Transcriptase Inhibitors in the Pre-partum Phase. ANRS 135 Primeva

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 105
Early research (Phase 1)Study completedNCT00001055
What this trial is testing

A Phase I Safety and Immunogenicity Trial of Live Recombinant Canarypox ALVAC-HIV (vCP205) in HIV-1 Uninfected Adult Volunteers

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 76
Testing effectiveness (Phase 2)Study completedNCT00109590
What this trial is testing

Reducing the Incidence of Nevirapine Resistance Mutations in Pregnant HIV Infected Women Who Receive Anti-HIV Drugs Prior to and After Giving Birth

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 175
Not applicableStudy completedNCT00218881
What this trial is testing

An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized Trial

Who this might be right for
HIV Counseling and TestingHIV Infections
North Bronx Healthcare Network 408
Early research (Phase 1)Study completedNCT00000774
What this trial is testing

A Phase I Study to Evaluate the Safety and Immunogenicity of Recombinant HIV-1 Envelope Antigen in Children Born to HIV-Infected Mothers

Who this might be right for
HIV InfectionsHIV Seronegativity
National Institute of Allergy and Infectious Diseases (NIAID) 156
Testing effectiveness (Phase 2)Study completedNCT00856323
What this trial is testing

Contingency Management for Methamphetamine Abstinence and HIV Post-Exposure Prophylaxis in Men Who Have Sex With Men

Who this might be right for
Amphetamine-Related DisordersHIVHIV Infections
Friends Research Institute, Inc. 53
Post-approval studies (Phase 4)Study completedNCT00405990
What this trial is testing

Male Partner Involvement in the Prevention of MTCT of HIV

Who this might be right for
HIV Infections
Imperial College London 1,000
Testing effectiveness (Phase 2)Study completedNCT01140880
What this trial is testing

Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men

Who this might be right for
HIV SeroconversionStimulant Abuse
Friends Research Institute, Inc. 170
Testing effectiveness (Phase 2)Study completedNCT00949234
What this trial is testing

Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV

Who this might be right for
HIV PreventionHIV Infections
University of California, Los Angeles 267
Early research (Phase 1)Study completedNCT00528489
What this trial is testing

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Early research (Phase 1)Study completedNCT00001053
What this trial is testing

A Phase I Safety and Immunogenicity Study of HIV p17/p24:Ty-VLP in HIV-1 Seronegative Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 36
Large-scale testing (Phase 3)Ended earlyNCT00153777
What this trial is testing

Cellulose Sulfate and HIV Transmission Among Women

Who this might be right for
HIV Infection
CONRAD 1,428
Testing effectiveness (Phase 2)Study completedNCT00007332
What this trial is testing

Safety and Immune Response Study of the Vaccine ALVAC vCP1452 Alone or in Combination With AIDSVAX B/B

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 330
Not applicableStudy completedNCT00249327
What this trial is testing

Online HIV Prevention Vignette Evaluation

Who this might be right for
HIV Infections
Public Health Solutions 1,000
Testing effectiveness (Phase 2)Study completedNCT00001031
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Reactogenicity of the Recombinant HIV-1 Envelope Vaccines SF-2 rgp120 (CHO) [Chiron Vaccines] in MF59 Adjuvant and MN rgp120/HIV-1 [VaxGen] in Alum Adjuvant in Healthy Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 296
Early research (Phase 1)Study completedNCT00000957
What this trial is testing

A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Vaccinia Derived HIV-1 Recombinant Envelope Glycoprotein (gp160) of Human Immunodeficiency Virus: Evaluation of Accelerated Schedules

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 30
Early research (Phase 1)Study completedNCT00089531
What this trial is testing

Candidate HIV Vaccine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 15
Early research (Phase 1)Study completedNCT00000795
What this trial is testing

A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Seronegative Human Subjects

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 28
Early research (Phase 1)Ended earlyNCT00623753
What this trial is testing

Evaluate Tolerability of a Multi-envelope, Prime-boost HIV Vaccine in Healthy Adults

Who this might be right for
HIV Infections
St. Jude Children's Research Hospital 3
Testing effectiveness (Phase 2)Study completedNCT00705705
What this trial is testing

Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks

Who this might be right for
HIV Infections
Medical College of Wisconsin 852
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation